Trending
•Ravi Mehta on building reasoning models that actually reason•StellarPay raises $40M to make cross-border payments invisible•The state of AI agents in 2026: the year tools become teammates•Small models are eating the enterprise — and saving fortunes doing it•SaaS margins are back — but only for the top quartile•Europe's $500M+ megarounds are back — three in the last sixty days•The first 100 customers playbook — what actually works in 2026•Verdant Labs wants to turn carbon removal into an industry•Ravi Mehta on building reasoning models that actually reason•StellarPay raises $40M to make cross-border payments invisible•The state of AI agents in 2026: the year tools become teammates•Small models are eating the enterprise — and saving fortunes doing it•SaaS margins are back — but only for the top quartile•Europe's $500M+ megarounds are back — three in the last sixty days•The first 100 customers playbook — what actually works in 2026•Verdant Labs wants to turn carbon removal into an industry
Founder Profile
Kavya Reddy
Founder & CEO, Helix Bio
Founder and CEO of Helix Bio. MD-PhD with postdoctoral training in CRISPR-based gene editing at Stanford. Left clinical practice to build programmable gene therapies addressed at the inherited diseases most prevalent across South Asia — conditions historically under-resourced by Western biotech.
India Helix Bio
Coverage of Kavya Reddy
No published stories yet.